MUC16 and leukemia: Beyond malignant tumors, increased levels of CA-125 have been observed in conditions such as early pregnancy, peritonitis, menstruation, nephrotic syndrome, endometriosis, leukemia, congestive heart failure, liver cirrhosis, pulmonary vascular disease, rheumatoid arthritis, and tuberculosis (7).